Request for Covid-19 Impact Assessment of this Report
The United States Female Sexual Dysfunction Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Female Sexual Dysfunction Treatment market, reaching US$ million by the year 2028. As for the Europe Female Sexual Dysfunction Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Female Sexual Dysfunction Treatment players cover AMAG Pharmaceuticals Inc., Duchesnay Inc., Emotional Brain BV, and Novo Nordisk AS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Female Sexual Dysfunction Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Non-hormonal Therapy
Hormonal Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Sexual Desire Disorders
Sexual Arousal Disorders
Orgasm Disorders
Sexual Pain Disorders
Post-orgasmic Diseases
Pelvic Floor Dysfunction
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AMAG Pharmaceuticals Inc.
Duchesnay Inc.
Emotional Brain BV
Novo Nordisk AS
Sprout Pharmaceuticals Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Female Sexual Dysfunction Treatment Market Size 2017-2028
2.1.2 Female Sexual Dysfunction Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Female Sexual Dysfunction Treatment Segment by Type
2.2.1 Non-hormonal Therapy
2.2.2 Hormonal Therapy
2.3 Female Sexual Dysfunction Treatment Market Size by Type
2.3.1 Female Sexual Dysfunction Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Female Sexual Dysfunction Treatment Market Size Market Share by Type (2017-2022)
2.4 Female Sexual Dysfunction Treatment Segment by Application
2.4.1 Sexual Desire Disorders
2.4.2 Sexual Arousal Disorders
2.4.3 Orgasm Disorders
2.4.4 Sexual Pain Disorders
2.4.5 Post-orgasmic Diseases
2.4.6 Pelvic Floor Dysfunction
2.4.7 Other
2.5 Female Sexual Dysfunction Treatment Market Size by Application
2.5.1 Female Sexual Dysfunction Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Female Sexual Dysfunction Treatment Market Size Market Share by Application (2017-2022)
3 Female Sexual Dysfunction Treatment Market Size by Player
3.1 Female Sexual Dysfunction Treatment Market Size Market Share by Players
3.1.1 Global Female Sexual Dysfunction Treatment Revenue by Players (2020-2022)
3.1.2 Global Female Sexual Dysfunction Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Female Sexual Dysfunction Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Female Sexual Dysfunction Treatment by Regions
4.1 Female Sexual Dysfunction Treatment Market Size by Regions (2017-2022)
4.2 Americas Female Sexual Dysfunction Treatment Market Size Growth (2017-2022)
4.3 APAC Female Sexual Dysfunction Treatment Market Size Growth (2017-2022)
4.4 Europe Female Sexual Dysfunction Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Female Sexual Dysfunction Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Female Sexual Dysfunction Treatment Market Size by Country (2017-2022)
5.2 Americas Female Sexual Dysfunction Treatment Market Size by Type (2017-2022)
5.3 Americas Female Sexual Dysfunction Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Female Sexual Dysfunction Treatment Market Size by Region (2017-2022)
6.2 APAC Female Sexual Dysfunction Treatment Market Size by Type (2017-2022)
6.3 APAC Female Sexual Dysfunction Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Female Sexual Dysfunction Treatment by Country (2017-2022)
7.2 Europe Female Sexual Dysfunction Treatment Market Size by Type (2017-2022)
7.3 Europe Female Sexual Dysfunction Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Female Sexual Dysfunction Treatment by Region (2017-2022)
8.2 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Female Sexual Dysfunction Treatment Market Forecast
10.1 Global Female Sexual Dysfunction Treatment Forecast by Regions (2023-2028)
10.1.1 Global Female Sexual Dysfunction Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Female Sexual Dysfunction Treatment Forecast
10.1.3 APAC Female Sexual Dysfunction Treatment Forecast
10.1.4 Europe Female Sexual Dysfunction Treatment Forecast
10.1.5 Middle East & Africa Female Sexual Dysfunction Treatment Forecast
10.2 Americas Female Sexual Dysfunction Treatment Forecast by Country (2023-2028)
10.2.1 United States Female Sexual Dysfunction Treatment Market Forecast
10.2.2 Canada Female Sexual Dysfunction Treatment Market Forecast
10.2.3 Mexico Female Sexual Dysfunction Treatment Market Forecast
10.2.4 Brazil Female Sexual Dysfunction Treatment Market Forecast
10.3 APAC Female Sexual Dysfunction Treatment Forecast by Region (2023-2028)
10.3.1 China Female Sexual Dysfunction Treatment Market Forecast
10.3.2 Japan Female Sexual Dysfunction Treatment Market Forecast
10.3.3 Korea Female Sexual Dysfunction Treatment Market Forecast
10.3.4 Southeast Asia Female Sexual Dysfunction Treatment Market Forecast
10.3.5 India Female Sexual Dysfunction Treatment Market Forecast
10.3.6 Australia Female Sexual Dysfunction Treatment Market Forecast
10.4 Europe Female Sexual Dysfunction Treatment Forecast by Country (2023-2028)
10.4.1 Germany Female Sexual Dysfunction Treatment Market Forecast
10.4.2 France Female Sexual Dysfunction Treatment Market Forecast
10.4.3 UK Female Sexual Dysfunction Treatment Market Forecast
10.4.4 Italy Female Sexual Dysfunction Treatment Market Forecast
10.4.5 Russia Female Sexual Dysfunction Treatment Market Forecast
10.5 Middle East & Africa Female Sexual Dysfunction Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Female Sexual Dysfunction Treatment Market Forecast
10.5.2 South Africa Female Sexual Dysfunction Treatment Market Forecast
10.5.3 Israel Female Sexual Dysfunction Treatment Market Forecast
10.5.4 Turkey Female Sexual Dysfunction Treatment Market Forecast
10.5.5 GCC Countries Female Sexual Dysfunction Treatment Market Forecast
10.6 Global Female Sexual Dysfunction Treatment Forecast by Type (2023-2028)
10.7 Global Female Sexual Dysfunction Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AMAG Pharmaceuticals Inc.
11.1.1 AMAG Pharmaceuticals Inc. Company Information
11.1.2 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
11.1.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AMAG Pharmaceuticals Inc. Main Business Overview
11.1.5 AMAG Pharmaceuticals Inc. Latest Developments
11.2 Duchesnay Inc.
11.2.1 Duchesnay Inc. Company Information
11.2.2 Duchesnay Inc. Female Sexual Dysfunction Treatment Product Offered
11.2.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Duchesnay Inc. Main Business Overview
11.2.5 Duchesnay Inc. Latest Developments
11.3 Emotional Brain BV
11.3.1 Emotional Brain BV Company Information
11.3.2 Emotional Brain BV Female Sexual Dysfunction Treatment Product Offered
11.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Emotional Brain BV Main Business Overview
11.3.5 Emotional Brain BV Latest Developments
11.4 Novo Nordisk AS
11.4.1 Novo Nordisk AS Company Information
11.4.2 Novo Nordisk AS Female Sexual Dysfunction Treatment Product Offered
11.4.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novo Nordisk AS Main Business Overview
11.4.5 Novo Nordisk AS Latest Developments
11.5 Sprout Pharmaceuticals Inc.
11.5.1 Sprout Pharmaceuticals Inc. Company Information
11.5.2 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
11.5.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sprout Pharmaceuticals Inc. Main Business Overview
11.5.5 Sprout Pharmaceuticals Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. Female Sexual Dysfunction Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Non-hormonal Therapy
Table 3. Major Players of Hormonal Therapy
Table 4. Female Sexual Dysfunction Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Female Sexual Dysfunction Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Female Sexual Dysfunction Treatment Market Size Market Share by Type (2017-2022)
Table 7. Female Sexual Dysfunction Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Female Sexual Dysfunction Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Female Sexual Dysfunction Treatment Market Size Market Share by Application (2017-2022)
Table 10. Global Female Sexual Dysfunction Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Female Sexual Dysfunction Treatment Revenue Market Share by Player (2020-2022)
Table 12. Female Sexual Dysfunction Treatment Key Players Head office and Products Offered
Table 13. Female Sexual Dysfunction Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Female Sexual Dysfunction Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Female Sexual Dysfunction Treatment Market Size Market Share by Regions (2017-2022)
Table 18. Americas Female Sexual Dysfunction Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Female Sexual Dysfunction Treatment Market Size Market Share by Country (2017-2022)
Table 20. Americas Female Sexual Dysfunction Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Female Sexual Dysfunction Treatment Market Size Market Share by Type (2017-2022)
Table 22. Americas Female Sexual Dysfunction Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Female Sexual Dysfunction Treatment Market Size Market Share by Application (2017-2022)
Table 24. APAC Female Sexual Dysfunction Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Region (2017-2022)
Table 26. APAC Female Sexual Dysfunction Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Type (2017-2022)
Table 28. APAC Female Sexual Dysfunction Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Application (2017-2022)
Table 30. Europe Female Sexual Dysfunction Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Country (2017-2022)
Table 32. Europe Female Sexual Dysfunction Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Type (2017-2022)
Table 34. Europe Female Sexual Dysfunction Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Female Sexual Dysfunction Treatment
Table 43. Key Market Challenges & Risks of Female Sexual Dysfunction Treatment
Table 44. Key Industry Trends of Female Sexual Dysfunction Treatment
Table 45. Global Female Sexual Dysfunction Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Female Sexual Dysfunction Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Female Sexual Dysfunction Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Female Sexual Dysfunction Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Female Sexual Dysfunction Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Female Sexual Dysfunction Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 51. AMAG Pharmaceuticals Inc. Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 52. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
Table 53. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. AMAG Pharmaceuticals Inc. Main Business
Table 55. AMAG Pharmaceuticals Inc. Latest Developments
Table 56. Duchesnay Inc. Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 57. Duchesnay Inc. Female Sexual Dysfunction Treatment Product Offered
Table 58. Duchesnay Inc. Main Business
Table 59. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Duchesnay Inc. Latest Developments
Table 61. Emotional Brain BV Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 62. Emotional Brain BV Female Sexual Dysfunction Treatment Product Offered
Table 63. Emotional Brain BV Main Business
Table 64. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Emotional Brain BV Latest Developments
Table 66. Novo Nordisk AS Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 67. Novo Nordisk AS Female Sexual Dysfunction Treatment Product Offered
Table 68. Novo Nordisk AS Main Business
Table 69. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Novo Nordisk AS Latest Developments
Table 71. Sprout Pharmaceuticals Inc. Details, Company Type, Female Sexual Dysfunction Treatment Area Served and Its Competitors
Table 72. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Offered
Table 73. Sprout Pharmaceuticals Inc. Main Business
Table 74. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Sprout Pharmaceuticals Inc. Latest Developments
List of Figures
Figure 1. Female Sexual Dysfunction Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Female Sexual Dysfunction Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Female Sexual Dysfunction Treatment Market Size Market Share by Type in 2021
Figure 7. Female Sexual Dysfunction Treatment in Sexual Desire Disorders
Figure 8. Global Female Sexual Dysfunction Treatment Market: Sexual Desire Disorders (2017-2022) & ($ Millions)
Figure 9. Female Sexual Dysfunction Treatment in Sexual Arousal Disorders
Figure 10. Global Female Sexual Dysfunction Treatment Market: Sexual Arousal Disorders (2017-2022) & ($ Millions)
Figure 11. Female Sexual Dysfunction Treatment in Orgasm Disorders
Figure 12. Global Female Sexual Dysfunction Treatment Market: Orgasm Disorders (2017-2022) & ($ Millions)
Figure 13. Female Sexual Dysfunction Treatment in Sexual Pain Disorders
Figure 14. Global Female Sexual Dysfunction Treatment Market: Sexual Pain Disorders (2017-2022) & ($ Millions)
Figure 15. Female Sexual Dysfunction Treatment in Post-orgasmic Diseases
Figure 16. Global Female Sexual Dysfunction Treatment Market: Post-orgasmic Diseases (2017-2022) & ($ Millions)
Figure 17. Female Sexual Dysfunction Treatment in Pelvic Floor Dysfunction
Figure 18. Global Female Sexual Dysfunction Treatment Market: Pelvic Floor Dysfunction (2017-2022) & ($ Millions)
Figure 19. Female Sexual Dysfunction Treatment in Other
Figure 20. Global Female Sexual Dysfunction Treatment Market: Other (2017-2022) & ($ Millions)
Figure 21. Global Female Sexual Dysfunction Treatment Market Size Market Share by Application in 2021
Figure 22. Global Female Sexual Dysfunction Treatment Revenue Market Share by Player in 2021
Figure 23. Global Female Sexual Dysfunction Treatment Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Female Sexual Dysfunction Treatment Market Size 2017-2022 ($ Millions)
Figure 25. APAC Female Sexual Dysfunction Treatment Market Size 2017-2022 ($ Millions)
Figure 26. Europe Female Sexual Dysfunction Treatment Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Female Sexual Dysfunction Treatment Market Size 2017-2022 ($ Millions)
Figure 28. Americas Female Sexual Dysfunction Treatment Value Market Share by Country in 2021
Figure 29. Americas Female Sexual Dysfunction Treatment Consumption Market Share by Type in 2021
Figure 30. Americas Female Sexual Dysfunction Treatment Market Size Market Share by Application in 2021
Figure 31. United States Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Region in 2021
Figure 36. APAC Female Sexual Dysfunction Treatment Market Size Market Share by Application in 2021
Figure 37. China Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Country in 2021
Figure 44. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Type in 2021
Figure 45. Europe Female Sexual Dysfunction Treatment Market Size Market Share by Application in 2021
Figure 46. Germany Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Female Sexual Dysfunction Treatment Market Size Market Share by Application in 2021
Figure 54. Egypt Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Female Sexual Dysfunction Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 60. APAC Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Europe Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 63. United States Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Canada Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Mexico Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 66. Brazil Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 67. China Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Japan Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Korea Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 71. India Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 72. Australia Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Germany Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 74. France Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 75. UK Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 76. Italy Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 77. Russia Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 78. Spain Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 79. Egypt Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 80. South Africa Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 81. Israel Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 82. Turkey Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries Female Sexual Dysfunction Treatment Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...